Should You Dump Sports Direct International Plc And Halfords Group plc And Buy GlaxoSmithKline plc?

Is it time for investors in Sports Direct International Plc (LON:SPD) and Halfords Group plc (LON:HFD) to consider a dose of GlaxoSmithKline plc (LON:GSK)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I’m asking whether the shine has come off two former retail high flyers and whether it’s time to focus on a different sector of the market.

Sports Direct, elusive growth

Shares in Sports Direct International (LSE: SPD) have continued to slide this morning after yesterday’s disappointing results. The sports retailer’s shares are now down by 30% from their 52-week high of 820p.

Sales growth during the first half of this year was below expectations. The firm’s underlying pre-tax profit of £166.4m was lower than expected and analysts now seem likely to cut their full-year profit forecasts.

In my view, shareholders face a dilemma. Sports Direct doesn’t pay a dividend, so investors have to rely on the firm’s share price rising to generate returns. The shares are now worth 23% less than two years ago and have fallen by 30% since August.

Will founder Mike Ashley pull something out of the hat to reignite the firm’s growth? Perhaps he will, but because he controls Sports Direct so closely, investors have little way of knowing what might happen.

Personally, it’s not a risk I’d choose to take, especially given the allegations made in the press this week about the firm’s employment and pricing practices.

Halfords, shares to get cheaper?

Shares in car parts and bicycle seller Halfords Group (LSE: HFD) have fallen by 38% from the 52-week high of 562p seen in August.

Like Sports Direct, Halfords’ most recent interim results were below expectations. Like-for-like sales growth of just 1.7% was down from 7% for the same period last year and was less than the 3% expected by City analysts.

However, there are some bright spots. Halfords’ free cash flow remains strong and should comfortably cover this year’s forecast 17p dividend. This gives a prospective yield of 4.9%. The firm’s shares now trade on just 10 times forecast earnings, suggesting that they’re becoming quite cheap.

For shareholders, I think Halfords is more attractive than Sports Direct. I wouldn’t sell, but I’m not sure I’d rush to buy today either. If Halfords has a quiet Christmas then the shares could get much cheaper and become a genuine bargain.

Why buy Glaxo instead?

Halfords and Sports Direct have both delivered strong growth over the last few years, but both firms appear to be entering a period of slower growth.

One firm that could be moving in the opposite direction is GlaxoSmithKline (LSE: GSK). Shares in the UK’s biggest pharmaceutical firm have fallen by around 20% over the last two years due to a period of weak earnings.

However, Glaxo’s recent multi-part deal with Novartis has strengthened and expanded the firm’s portfolio in key growth areas such as vaccines and consumer health. The deal also helped fund a $4bn reduction in net debt to $10.5bn. That’s the lowest level since 2011.

City brokers now believe that Glaxo is poised for a period of growth. Earnings per share are expected to rise by 16% to 76p for 2015 and then by a further 10% to 84p in 2016.

Glaxo shares offer a 6% prospective yield and are currently trading close to their 52-week low. I rate Glaxo as a good long term buy.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline and Sports Direct International. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young female business analyst looking at a graph chart while working from home
Investing Articles

Is Avon Protection the best stock to buy in the FTSE All-Share index right now?

Here’s a stock I’m holding for recovery and growth from the FTSE All-Share index. Can it be crowned as the…

Read more »

Investing Articles

Down 8.5% this month, is the Aviva share price too attractive to ignore?

It’s time to look into Aviva and the insurance sector while the share price is pulling back from year-to-date highs.

Read more »

Investing Articles

Here’s where I see Vodafone’s share price ending 2024

Valued at just twice its earnings, is the Vodafone share price a bargain or value trap? Our writer explores where…

Read more »

Businesswoman analyses profitability of working company with digital virtual screen
Investing Articles

The Darktrace share price jumped 20% today. Here’s why!

After the Darktrace share price leapt by a fifth in early trading, our writer explains why -- and what it…

Read more »

Dividend Shares

850 shares in this dividend giant could make me £1.1k in passive income

Jon Smith flags up one dividend stock for passive income that has outperformed its sector over the course of the…

Read more »

Investing Articles

Unilever shares are flying! Time to buy at a 21% ‘discount’?

Unilever shares have been racing higher this week after a one-two punch of news from the company. Here’s whether I…

Read more »

artificial intelligence investing algorithms
Market Movers

The Microsoft share price surges after results. Is this the best AI stock to buy?

Jon Smith flags up the jump in the Microsoft share price after the latest results showed strong demand for AI…

Read more »

Google office headquarters
Investing Articles

A dividend announcement sends the Alphabet share price soaring. Here’s what investors need to know

As the Alphabet share price surges on the announcement of a dividend, Stephen Wright outlines what investors should really be…

Read more »